tiprankstipranks
Cansortium (CNTMF)
OTHER OTC:CNTMF
Holding CNTMF?
Track your performance easily

Cansortium (CNTMF) Stock Price & Analysis

72 Followers

CNTMF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

15.09%0.06%82.01%
15.09% Insiders
― Other Institutional Investors
82.01% Public Companies and
Individual Investors

CNTMF FAQ

What was Cansortium’s price range in the past 12 months?
Cansortium lowest stock price was $0.06 and its highest was $0.29 in the past 12 months.
    What is Cansortium’s market cap?
    Currently, no data Available
    When is Cansortium’s upcoming earnings report date?
    Cansortium’s upcoming earnings report date is May 05, 2025 which is in 94 days.
      How were Cansortium’s earnings last quarter?
      Cansortium released its earnings results on Nov 29, 2024. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.04.
        Is Cansortium overvalued?
        According to Wall Street analysts Cansortium’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cansortium pay dividends?
          Cansortium does not currently pay dividends.
          What is Cansortium’s EPS estimate?
          Cansortium’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cansortium have?
          Cansortium has 447,512,300 shares outstanding.
            What happened to Cansortium’s price movement after its last earnings report?
            Cansortium reported an EPS of -$0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.091%.
              Which hedge fund is a major shareholder of Cansortium?
              Currently, no hedge funds are holding shares in CNTMF
              ---

              Company Description

              Cansortium

              Cansortium, Inc. engages in the production and sale of medical cannabis. It focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale, and distribution of processed cannabis oil in medical use frameworks. The company was founded on August 31, 2018 and is headquartered in Miami, FL.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              High Tide
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis